Kissei Pharmaceutical Co., Ltd.
Clinical trials sponsored by Kissei Pharmaceutical Co., Ltd., explained in plain language.
-
New hope for endometriosis pain: phase 3 trial launches
Symptom relief OngoingThis study tests a new drug, KLH-2109, to see if it works as well as a standard treatment (leuprorelin) for reducing pelvic pain in people with endometriosis. About 288 premenopausal women aged 18 and older with confirmed endometriosis will take part. The main goal is to measure …
Phase: PHASE3 • Sponsor: Kissei Pharmaceutical Co., Ltd. • Aim: Symptom relief
Last updated May 17, 2026 17:11 UTC
-
New pill may ease movement problems in advanced Parkinson's
Symptom relief OngoingThis study tests a new drug, KDT-3594, in 150 people with advanced Parkinson's disease who already take levodopa. The goal is to see if the drug can improve movement and daily living skills over 17 weeks. Participants receive either the study drug or a placebo, and researchers me…
Phase: PHASE2 • Sponsor: Kissei Pharmaceutical Co., Ltd. • Aim: Symptom relief
Last updated May 15, 2026 11:57 UTC